West Pharmaceutical Services, Inc. - WST Enterprise Value-to-Revenue Multiple

West Pharma (WST) - corporate logo

West Pharmaceutical Services (WST) dominates the injectable packaging segment, integrating itself into the developments of the largest pharmaceutical companies. The EV/Sales valuation confirms the market value, where the indicator reaches 8089.61. Business efficiency relies on external sterilization and IT outsourcing. Low geopolitical risks guarantee the stability of supplies for critical humanitarian infrastructure worldwide.

WST: West Pharma Company Value to Revenue 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for West Pharma Corp (WST)

- cash and cash flow indicators:
Fundamental company valuation:WST, westpharma.com
Original product of West Pharmaceutical Services Inc

The EV/Sales metric assesses the market value of a business relative to its revenue, excluding the impact of debt load to determine the company's fundamental stability. The current value of 8089.61 reflects a premium for the technological leadership of West Pharmaceutical Services (WST) in sterile zone automation and the implementation of AI control. By analyzing the EV/Sales trajectory on the GURU.Markets platform, an investor can assess the risk of asset overvaluation and the portfolio's margin of safety.

Competitor analysis

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio BAX (Baxter International)|Enterprise Value-to-Revenue Ratio Masimo (MASI)|Stevanato Group - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio Teleflex Inc. TFX|Enterprise Value-to-Revenue Coefficient MMSI (Merit Medical Systems, Inc.)|NVST - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio ICU Medical Corp ICUI|XRAY: EV/Sales Multiple|LMAT (LeMaitre Vascular, Inc.) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue ATRC|STAA (STAAR Surgical) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ChromaDex (NAGE)|Company Value to Revenue ZimVie Inc. ZIMV|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple